Big effect
Kefir slashed HOMA-IR by 1.71 points in a meta-analysis — but the same review found no effect on weight, waist size, cholesterol, or inflammation.
This is a large, statistically significant drop in a key marker of insulin resistance, but it comes from only three studies, and the fact that kefir didn't budge any other metabolic or inflammatory measure means the benefit appears narrow — and may not translate into the broader health improvements you'd expect.
HOMA-IR is a score that estimates how resistant your cells are to insulin; a drop of 1.71 is substantial (think of it as moving from prediabetic range toward normal). However, the same analysis found kefir had no effect on body weight, BMI, waist circumference, cholesterol, triglycerides, or inflammatory markers — so while it may improve how your body handles blood sugar, it's not a metabolic cure-all.
Where this fits in the evidence
Pillser has synthesized 3 studies on Kefir for Reduced HOMA-IR — overall evidence strength: Moderate.
Across 3 studies, all reported beneficial effects on HOMA-IR, with effect sizes ranging from small to large. Two meta-analyses found large reductions (WMD -2.56, 95% CI: -3.82 to -1.30; MD -1.71, p=0.004), while a single RCT observed a small within-group decrease that was not statistically significant compared to the placebo (unfermented milk) group. The median study duration was 84 days (from one study).
The study
- Meta-Analysis
- 2026-05
- Nutrition, metabolism, and cardiovascular diseases : NMCD
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.